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Essential and dispensable roles
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A Cre/lox-conditional mouse line was generated to evaluate the role of ATR in checkpoint responses to
ionizing radiation (IR) and stalled DNA replication. We demonstrate that after IR treatment, ATR and ATM
each contribute to early delay in M-phase entry but that ATR regulates a majority of the late phase (2–9 h
post-IR). Double deletion of ATR and ATM eliminates nearly all IR-induced delay, indicating that ATR and
ATM cooperate in the IR-induced G2/M-phase checkpoint. In contrast to the IR-induced checkpoint,
checkpoint delay in response to stalled DNA replication is intact in ATR knockout cells and ATR/ATM and
ATR/p53 double-knockout cells. The DNA replication checkpoint remains intact in ATR knockout cells even
though the checkpoint-stimulated inhibitory phosphorylation of Cdc2 on T14/Y15 and activating
phosphorylation of the Chk1 kinase no longer occur. Thus, incomplete DNA replication in mammalian cells
can prevent M-phase entry independently of ATR and inhibitory phosphorylation of Cdc2. When DNA
replication inhibitors are removed, ATR knockout cells proceed to mitosis but do so with chromosome
breaks, indicating that ATR provides a key genome maintenance function in S phase.
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DNA damage checkpoints are feedback mechanisms
that sense the physical state of the genome. Should the
integrity of the genome be compromised, checkpoint
proteins signal these events and thereby prevent initia-
tion of the next cell cycle phase. To do so, DNA damage
checkpoint proteins interface with and inhibit the Cdk/
cyclin machinery, the normal function of which is to
activate and coordinate genome duplication and parti-
tioning (Zhou and Elledge 2000; Nyberg et al. 2002). In
mammalian cells, two important regulators of DNA
damage checkpoints are ATR and ATM, unconventional
protein kinases that phosphorylate and activate signal
transduction pathways that ultimately interface with
the Cdk/Cyclin machinery.
ATR and ATM are structurally and functionally simi-
lar to two checkpoint genes in yeast, MEC1 (Saccharo-
myces cerevisiae) and RAD3 (Schizosaccharomyces
pombe), which regulate analogous pathways to control
the cell cycle machinery. However, whereas Mec1 and
Rad3 regulate nearly all responses to damage or inhibited
DNA replication in their respective organisms, check-
point regulation in mammals appears to be unevenly di-
vided between ATR and ATM. Based mostly on studies
of signal transduction pathways activated upon DNA
damage and stalled DNA replication, ATR has been
shown to regulate responses to a broad range of damage,
including pyrimidine dimers, stalled replication, and
double-stand breaks (DSBs). ATM, on the other hand,
seems to be more specifically involved in responses to
DSBs (Zhou and Elledge 2000; Nyberg et al. 2002). For
example, through dominant-negative overexpression
studies, ATR has been implicated in the regulation of IR-
and ultraviolet light (UV)-induced phosphorylation of
p53 on serine 15 (S15) and UV- and aphidicolin-induced
phosphorylation of the Chk1 protein kinase on S345
(Tibbetts et al. 1999; Liu et al. 2000; Zhao and Piwnica-
Worms 2001). In addition, a recently generated Cre/lox-
conditional cell line has been used to demonstrate that
ATR is required for phosphorylation of Rad17 in re-
sponse to UV (Zou et al. 2002). In contrast to ATR defi-
ciency, ATM loss predominantly affects responses to
DSBs, such as IR-induced phosphorylation of the Chk2
protein kinase, S15 p53, NBS1, and other proteins (Mat-
suoka et al. 1998; Kastan and Lim 2000).
Although the effects of ATR dominant-negative over-
expression and ATM loss on signaling pathways have led
to a relatively simple model of checkpoint regulation,
the comparative requirements for ATR and ATM in ul-
timately preventing cell cycle progression has remained
less clear. For example, although both ATR and ATM
have each been shown to play a role in preventing mi-
totic entry in response to IR (Cliby et al. 1998; Cortez et
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al. 2001; Xu et al. 2002), it is unknown whether ATR and
ATM regulate this response in an additive or epistatic
manner or whether one protein may play a more impor-
tant role than the other. Moreover, ATR’s involvement
in preventing mitotic entry in response to stalled DNA
replication has remained particularly obscure. Although
in vitro experiments using Xenopus extracts have shown
an important role for ATR in preventing nuclear enve-
lope breakdown upon inhibition of DNA synthesis (Guo
et al. 2000; Hekmat-Nejad et al. 2000), systems using
dominant-negative ATR overexpression have led to con-
tradictory results in mammalian cells (Cliby et al. 1998;
Nghiem et al. 2001, 2002). At the present time, it is not
clear whether these contradictory results may be caused
by differences in the degree of dominant-negative over-
expression or in the undefined genetic background of the
tumor cell lines used. Adding to the complexity of ATR’s
role in the DNA replication checkpoint are recent stud-
ies in yeast that imply a role for ATR in preventing DSBs
in response to stalled replication (Lopes et al. 2001; Cha
and Kleckner 2002). Because one would then expect
stalled replication forks to be converted into DSBs in the
absence of ATR, it is difficult to predict if the DNA
replication checkpoint would be eliminated by ATR de-
ficiency. Loss of genome stability in ATRmutants could
contribute to cell cycle inhibition upon replication arrest
and do so in an ATR-independent manner.
To compare the role of ATR and ATM in cell cycle
checkpoint control, a mouse line expressing a Cre/lox-
conditional allele of ATR was generated. This system
allowed comparison of checkpoint requirements for
ATR and ATM in cells that are untransformed and of an
isogenic background. Using ATRflox/−, ATM−/−, and
ATRflox/− ATM−/− murine embryonic fibroblasts (MEFs),
we have assessed the roles of ATR and ATM in check-
point responses to IR and stalled DNA replication. In
response to IR, we show that ATR contributes to pre-
venting mitotic entry in a time-dependent manner, regu-
lating the late phase of the response and cooperating
with ATM in the early phase. Because little or no delay
is observed in IR-treated ATR/ATM double knockouts,
these results indicate that together these genes regulate
a majority of the response to IR that inhibits mitotic
entry. However, in contrast to IR-induced checkpoint
responses, we have found that delayed mitotic entry in
response to stalled DNA replication occurs even when
ATR and ATM are deleted. This delay is evident despite
the fact that ATR is required both for phosphorylation of
Chk1 and for inhibitory phosphorylation of Cdc2 in re-
sponse to either IR or stalled replication. Furthermore,
although we find that DSBs are, indeed, generated spe-
cifically in ATR knockout cells upon DNA replication
stalling, these breaks themselves do not prevent mitotic
entry once DNA replication inhibitors are removed.
These data show that both IR- and aphidicolin-induced
checkpoints use ATR for signaling events that ulti-
mately lead to inhibitory phosphorylation of Cdc2;
however, in response to stalled replication, at least one
additional mechanism must be at work in preventing
mitotic entry.
Results
Generation of a lox-conditional allele of ATR
Previous ATR knockout studies demonstrated that ATR
is required for genomic stability in the early embryo and
that its loss leads to early embryonic lethality (Brown
and Baltimore 2000). To further explore the cellular
functions of ATR in cell cycle regulation and genome
maintenance, a Cre/lox-conditional allele of ATR was
generated in mice. Murine genomic clones of the 3 end
of the ATR locus were mapped and sequenced to reveal
two exons encoding essential components of the ATR
kinase domain (KD1 and KD2), including the catalytic
residues conserved in human ATR, D2475 and D2494
(Fig. 1A). lox sites were placed on each side of a 1.2-kb
region that includes KD1 and KD2 in the ES cell target-
ing vector shown (Fig. 1A). Upon lox recombination of
this allele, KD1 and KD2 deletion and a subsequent
frameshift in 3 exons is predicted, thereby truncating
the ATR gene product 5 of KD1 (amino acid 2398). Fol-
lowing transfection and selection of D3 ES cells, recom-
bination into the ATR locus was confirmed by Southern
blot hybridization to two probes generated from se-
quences 5 and 3 of the targeted region; detection of a
22.5-kb BamHI–KpnI (5-probe) and an 11.5-kb HindIII
(3-probe) band indicated appropriate recombination (Fig.
1A,B, Recombined). Note that when recombinatorial
crossover occurs within the 1.2-kb KD1/KD2 region
rather than outside of it, then 19.5-kb BamHI–KpnI and
18-kb HindIII bands are generated (Fig. 1A,B, Internal
rec.). Appropriately targeted ES cells were then trans-
fected with a vector expressing FLP recombinase (Buch-
holz et al. 1998) to remove the selection cassette by frt
recombination (Fig. 1A). Removal of the selection cas-
sette resulted in an allele in which KD1 and KD2 are
flanked by lox sites and only a single frt site remains (Fig.
1A). This final configuration was detected by a 4.5-kb
decrease in the BamHI–KpnI fragment length to 18 kb
(Fig. 1A,B, Conditional). An ES cell clone with this con-
figuration was subsequently used to generate chimeric
mice, 3 in 10 of which transmitted the lox-conditional
ATR allele through the germ line. In the studies de-
scribed below, this conditional allele is abbreviated as
ATRflox, and the following lox recombination is referred
to as ATR.
ATR/− cells divide normally 1–2 times after ATR loss
and then exit the cell cycle
To study the effect of ATR loss in primary cell prolifera-
tion, embryonic day 14.5 (E14.5) embryos isolated from
parental crosses of ATRflox/+ with ATR+/− (Brown and
Baltimore 2000) mice were used to generate wild-type,
ATR+/−, ATRflox/+, and ATRflox/− murine embryonic fi-
broblasts (MEFs). Previously, we have shown that ATR
is required for proliferation of early embryonic cells in
culture (Brown and Baltimore 2000). To test if E14.5
MEFs also require ATR, the ATRflox/− and control cells
described above were infected with a lentivirus that ex-
Brown and Baltimore
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presses EGFP fused to a nuclear-localized form of Cre
recombinase (NLS-Cre). Cells initially expressing the
EGFP–Cre fusion protein were then followed for contin-
ued representation in proliferating cultures by flow cy-
tometry over the course of 8 d (Fig. 2A). A selective loss
ofATRflox/− cells expressing EGFP–Cre was observed 5 to
8 d after infection. However, because lox recombination
was typically complete within 36 h of Cre expression
(data not shown), these results indicated that ATR-de-
pleted cells may divide normally soon after ATR deple-
tion, but ultimately exit the cell cycle.
To test this possibility, ATRflox/− and wild-type cells
were synchronized in G0 by culturing in reduced serum
(0.5% FBS) for 1 d and were then infected with Cre-ex-
pressing lentivirus at near saturation levels (>90% in-
fected). These wild-type and ATR/− cultures were then
maintained in reduced serum for an additional 2 d and
subsequently stimulated with 10% FBS for 18 to 24 h.
Whereas ATR was depleted within 60 h of lenti-Cre in-
fection (Fig. 2B), little difference was observed in the
ability of lenti-Cre-infected ATRflox/− and wild-type cells
to enter S and G2/M phase within 24 h of FBS stimula-
tion (66–72 h after lenti-Cre infection; Fig. 2C). However,
2–6 d of continued culture in growth media resulted in a
loss of proliferation accompanied by the appearance of
large flattened cells (Fig. 2D) and a small increase in An-
nexin V staining (less than twofold over wild type). Thus,
although ATR is required for long-term proliferation,
ATR-depleted cells exhibit a relatively normal cell divi-
sion cycle soon after ATR loss.
ATR and ATM cooperate in preventing mitotic entry
in response to IR
The synchronization, infection, and serum-restimula-
tion procedure described above and in Figure 2B and C,
Figure 1. Generation of a floxed conditional allele of ATR (ATRflox). (A) Schematic representations of the targeting vector, wild-type
ATR locus, recombined locus, and the final conditional allele of ATR (ATRflox) are shown. Following confirmation by Southern blot,
the ES cells with a recombined ATR allele were transfected with the pCAGGS-FLPe expression vector (Buchholz et al. 1998) to remove
the selection cassette. Removal of the selection cassette results in the lox-conditional (ATRflox) allele shown. (B) Confirmation of the
ATRflox allele by Southern blot. DNA prepared from ES cell clones was digested with BamHI + KpnI or HindIII alone and Southern-
blotted for hybridization with the 5 and 3 probes indicated in A, respectively. DNA fragments representing wild-type, internally
recombined, recombined, and ATRflox alleles are discussed in the text and indicated in A.
ATR’s role in checkpoints and genome maintenance
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provided a system to analyze ATR’s role in cell cycle
checkpoint regulation. Because previous studies have at-
tributed IR-induced checkpoint responses to both ATR
and ATM (Cliby et al. 1998; Cortez et al. 2001; Xu et al.
2002), we first wished to clarify the roles of ATR and
ATM in this response using a defined genetic back-
ground and in the context of a single cell type (MEFs). To
compare the roles of ATR and ATM in this checkpoint
response, serum-starved wild-type, ATRflox/−, and
ATM−/− MEFs were infected with Cre-expressing lenti-
virus and restimulated with serum as described above
(Fig. 2B,C). After 17 h of FBS stimulation, ATR/− and
control cells began to enter mitosis (Fig. 3B). Cells were
exposed to 20 Gy of -radiation at this time and were
subsequently treated with nocodazole (0.5 µM) for 5 h to
allow accumulation in mitosis. Entry into mitosis was
then analyzed in two ways. In the first, mitotic spreads
were prepared, and the ratio of mitotic and interphase
cells was counted (Fig. 3A, panel 1). In the second, cells
were stained for phosphohistone H3, a mitotic marker,
and analyzed by flow cytometry (Fig. 3A, panel 2). Using
either form of quantitation, these data demonstrated
that ATR plays an important role in preventing cells
from entering mitosis after IR exposure and by this
analysis appeared to play a more important role than
ATM (Fig. 3A). Using a 10-Gy dose, a similar level of
ATR dependence for checkpoint delay was observed
(data not shown). It is important to point out that noco-
dazole “pile up” nullifies temporal differences in mitotic
entry by collecting mitotic cells over a set course of
time, in this case 5 h. Because complete loss of check-
point function was not observed in either single knock-
out, we thought these genes might cooperate in the IR
response, perhaps in a temporal manner. Evidence in
support of ATM contributing to early delays in M phase
entry in response to IR has been reported (Xu et al. 2002).
To test if ATR plays a time-dependent role in IR-in-
duced responses, ATR-depleted and wild-type MEFs
were assayed for the rate of entry into mitosis after ex-
posure to IR at 17 h of FBS stimulation (Fig. 3B). Noco-
Figure 2. ATR/− cells divide and then
exit the cell cycle. (A) Asychronously ex-
panding ATRflox/− MEFs expressing EGFP–
Cre are selectively lost from culture. The
cells that continue to express EGFP–Cre
over the course of 8 d of growth were quan-
titated as a percentage of their initial rep-
resentation 1 d after infection with lenti-
EGFP–Cre. , wild type; , ATR+/−; ,
ATRflox/+; , ATRflox/−. (B) Western blot
quantitation of ATR protein levels in
ATRflox/− and ATR+/− MEFs 60 h after
NLS-Cre expression (lenti-Cre). (C) Cell
cycle analysis of lenti-Cre-infected wild-
type and ATRflox/− MEFs. DNA content
was determined by propidium iodide
staining and flow cytometric analysis. (D)
Exit of ATR/− cells from the cell cycle.
Cells treated as in C are shown after 1 and
6 d of FBS stimulation. Cells were split 1:4
at day 3.
Brown and Baltimore
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dazole treatment was not used in these experiments;
therefore, the percentage of mitotic cells represents nor-
mal entry into mitosis following FBS stimulation. As
shown in Figure 3B, ATR is required for the late phase of
the response, beginning ∼3–4 h after IR treatment, but it
is less important for the checkpoint response soon after
IR exposure (e.g., 1 h after IR). To test if ATM plays a role
in the early phase of the response in the context of this
system, the ATRflox allele was bred into an ATM knock-
out background, and the same assay was performed (Fig.
3C). Whereas ATR and ATM individually played only
partial and time-dependent roles in this checkpoint re-
sponse, ATR/ATM double-knockout cells entered mito-
sis similarly to unirradiated cells. Because significant de-
lay was not observed either early or late in the response,
these data indicate that a majority, if not all, of IR-in-
duced cell cycle delay is governed cooperatively by ATR
and ATM (Fig. 3C).
To further analyze the time-dependent requirement
for ATR and ATM, p53 S18 phosphorylation was ana-
lyzed for its kinetic dependence on ATR and ATM. S18
phosphorylation has been shown to be important for
p53’s checkpoint activity in the mouse (Chao et al.
2000), and phosphorylation of the sequence-context
equivalent in human cells (S15) has previously been sug-
gested to be ATR-dependent in the late phase based on
dominant-negative ATR overexpression (Tibbetts et al.
1999). Figure 3D and E shows that consistent with the
Figure 3. ATR and ATM cooperate in checkpoint responses to -irradiation. (A) Serum-deprived and lenti-Cre-infected wild-type,
ATRflox/−, and ATM−/− MEFs were -irradiated (20 Gy) after 17 h of FBS stimulation and then treated with 0.5 µM nocodazole for 5 h
(corresponding to 18–23 h of FBS stimulation). The percentage of cells exhibiting chromosome condensation (panel 1) and phosphory-
lated histone H3 (panel 2) were quantitated by chromosome spread preparation and immunostaining, respectively. Differences be-
tween the total percent of cells with condensed chromatin (panel 1) versus phosphohistone H3 staining (panel 2) is consistent with the
phosphorylation of histone H3 occurring prior to condensation and remaining phosphorylated throughout M phase. (B) ATR is required
for late-phase mitotic delay in response to IR. Entry into mitosis (without nocodazole treatment) was quantitated by phosphohistone
H3 staining before and after treatment with 20 Gy of -radiation at 17 h of FBS stimulation., wild-type;,ATR/−;, wild-type + IR;
, ATR/− + IR. (C) ATR and ATM cooperate in the cell cycle delay elicited by IR. Mitotic entry was assessed after IR exposure as in
B to compare mitotic entry of ATRflox/− (no lenti-Cre infection), ATM−/−, and lenti-Cre-infected ATRflox/− and ATRflox/− ATM−/−
(ATR/− andATR/−ATM−/−) MEFs.ATRflox/− andATRflox/−ATM−/− MEFs were derived from embryonic littermates. (D) ATR and ATM
cooperate in p53 S18 phosphorylation. Lysates generated from lenti-Cre-infected wild-type, ATRflox/−, and ATM−/− cells at various
times after IR treatment were Western-blotted and detected with a phospho-specific antibody to phospho-S18 p53. (E) Cells treated as
described inCwere analyzed for p53 S18 phosphorylation byWestern blot detection as described inD. Error bars represent the standard
deviation (S.D.) from the mean of values obtained in these experiments. nt, not treated with IR.
ATR’s role in checkpoints and genome maintenance
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assay for mitotic entry, p53 phosphorylation appears to
require both ATR and ATM in a time-dependent manner
and that both ATR and ATM must be deleted to prevent
phosphorylation over the long term.
In response to stalled DNA replication, cell cycle
delay is intact in ATR and ATR/ATM
double-knockout cells
After assessing ATR’s role in IR-induced checkpoint
regulation, we set out to determine if ATR was required
in a similar manner for other checkpoint responses, such
as the cell cycle delay resulting from stalled DNA repli-
cation. Three assays were used to quantitate mitotic en-
try: histone H3 phosphorylation, Cdc2/Cyclin B1 activa-
tion, and chromosome condensation. First, in a time-
course assay similar to that used for IR-induced delay,
wild-type and ATR/− cells were treated or left untreated
with aphidicolin (5 µM) as cells began to pass into S
phase, 15 h after FBS stimulation; cells subsequently en-
tering mitosis were quantitated by phosphohistone H3
staining. Surprisingly, aphidicolin treatment potently in-
hibited both wild-type and ATR/− cells from entering
mitosis (Fig. 4A). To further examine this inhibition, cy-
clin B1-associated H1 kinase activity was assayed 3–9 h
after aphidicolin or IR treatment (Fig. 4B). Consistent
with the loss of IR-induced mitotic delay in ATR/− cells
(Fig. 3), cyclin B1-associated H1 kinase activity was not
significantly inhibited by IR exposure (Fig. 4); however,
H1 kinase activity was inhibited by aphidicolin treat-
ment of either wild-type or ATR/− cells (Fig. 4). Finally,
ATR’s role in the DNA replication checkpoint was ex-
amined by quantitating the percentage of cells with con-
densed chromatin (Fig. 4C). These results also showed
that ATR is dispensable for preventing mitotic entry in
response to stalled DNA replication (Fig. 4C).
Because ATM cooperates with ATR in IR-induced re-
sponses (Fig. 3), we wondered if ATM may be compen-
sating in the DNA replication checkpoint for ATR’s loss.
It was also possible that p53 may cooperate with ATR in
this checkpoint, as suggested by ATR dominant-negative
studies (Nghiem et al. 2002). To test these possibilities,
the checkpoint function of ATR/− cells was compared
with that of ATR/− ATM−/− and ATR/− p53−/− double-
knockout MEFs (Fig. 4D). In each case, the DNA repli-
cation checkpoint function remained intact. These re-
sults demonstrate that ATR and ATM are dispensable for
preventing mitotic entry upon stalled DNA replication.
Roles of ATR and ATM in Chk1 and Chk2 regulation
The ability of ATR knockout cells to arrest normally in
the face of stalled DNA replication is surprising given
numerous reports of ATR’s role in regulating down-
stream signaling events, such as the phosphorylation of
Chk1 (Guo et al. 2000; Hekmat-Nejad et al. 2000; Liu et
al. 2000; Zhao and Piwnica-Worms 2001). To confirm
ATR’s role in regulating downstream signaling events
using the ATR knockout system described herein, wild-
type and ATR/− cells were treated with aphidicolin (5
µM) or exposed to 20 Gy of -radiation, and cells were
harvested at various times posttreatment for Western
blot analysis (Fig. 5A). Chk1 phosphorylation was then
evaluated by both detection with phospho-specific anti-
bodies to serine 345 (Liu et al. 2000) and bymobility shift
(Sanchez et al. 1997; Kumagai et al. 1998). In wild-type
cells, Chk1 phosphorylation was strongly increased in
response to aphidicolin treatment and moderately to
weakly increased following exposure to IR. Note that
multiple forms of decreased electrophoretic mobility
were detected, similar to those observed for Xenopus
Chk1 upon in vitro phosphorylation (Kumagai et al.
1998; Guo et al. 2000; Hekmat-Nejad et al. 2000). In
ATR/− cells, both aphidicolin- and IR-induced phos-
phorylation of Chk1 was inhibited, confirming an im-
portant role for ATR in regulating Chk1.
We then analyzed phosphorylation of Chk2 to deter-
mine its requirements for ATR and ATM in response to
stalled replication. Whereas ATR deletion had no inhibi-
tory effect on either the potent IR-induced phosphoryla-
tion of Chk2 or the mild phosphorylation resulting from
aphidicolin treatment (Fig. 5B), ATM deletion prevented
most of the mild aphidicolin-induced phosphorylation
(Fig. 5B), consistent with previous studies using IR (Mat-
suoka et al. 1998). Therefore, because the DNA replica-
tion checkpoint remains intact even in ATR/− ATM−/−
cells (Fig. 4D), mitotic delay in response to stalled repli-
cation cannot be solely through Chk2 phosphorylation.
It is also important to point out that the late phase of
IR-induced Chk2 phosphorylation in ATR/− cells (Fig.
5B) is not sufficient to prevent mitotic entry (Fig. 3B),
indicating that moderate to high levels of Chk2 phos-
phorylation are incapable of generating delay on their
own. Thus, in regard to the checkpoint response to
stalled replication, our studies indicate that the ATR–
Chk1 and ATM–Chk2 pathways are dispensable for the
mitotic delay induced by DNA replication inhibitors.
Checkpoint-induced inhibitory phosphorylation
of Cdc2 on T14 and Y15 is ATR-dependent
Although ATR and ATM are required for cell cycle delay
in response to IR, the results described above indicate
that ATR and ATM and the activation of Chk1 and Chk2
are dispensable for the ultimate cell cycle arrest that
occurs in response to stalled DNA replication. Chk1 and
Chk2 are upstream regulators of several signaling path-
ways that ultimately control phosphorylation of Cdc2 on
threonine 14 (T14) and tyrosine 15 (Y15), thereby inhib-
iting Cdc2’s catalytic activity (Norbury and Nurse 1992;
Nyberg et al. 2002). Given that inhibitory phosphoryla-
tion of Cdc2 on T14 and Y15 is an important mode of cell
cycle regulation in metazoans and fission yeast (Norbury
and Nurse 1992; Nyberg et al. 2002), it was conceivable
that stalled DNA replication may somehow bypass
Chk1 and Chk2 to control Cdc2 activity through T14/
Y15 phosphorylation. The phosphorylation state of Cdc2
Brown and Baltimore
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on T14 and Y15 was therefore assessed in aphidicolin-
treated wild-type and ATR/− cells and compared with
that of IR-treated cells.
Cdc2 is initially phosphorylated in S phase by the
Wee1 and Myt1 kinases (Norbury and Nurse 1992; Ny-
berg et al. 2002). This phosphorylation is maintained un-
til the early stages of mitosis, at which time these phos-
phates are removed by changes in the rates of phosphory-
lation and dephosphorylation. As indicated by slowed
electrophoretic mobility, the well-characterized phos-
phorylation of Cdc2 was observed in both ATR/− and
control cells upon serum-stimulated entry into S and G2
phase 18 h after FBS stimulation (Fig. 6A). Therefore,
ATR is not required for the initial phosphorylation of
Cdc2 that occurs upon S-phase entry. To examine the
ability of DNA damage or stalled replication to maintain
Cdc2 phosphorylation, wild-type and ATR/− cells were
treated with aphidicolin or IR for 9 and 12 h, and the
accumulation of the T14/Y15-phosphorylated form of
Cdc2 was assessed by Western blot (Fig. 6B). In wild-type
cells, this accumulation occurred as expected over the
course of treatment. In ATR/− cells, however, increased
phosphorylation of Cdc2 was not observed following
treatment with either aphidicolin or IR (Fig. 6B). To-
gether these data indicate that both IR- and aphidicolin-
induced checkpoints use ATR for signaling events that
ultimately lead to inhibitory phosphorylation of Cdc2;
however, an additional mechanism to prevent cell cycle
progression must be at work when DNA replication is
incomplete.
ATR prevents generation of double-strand breaks
in the event of stalled DNA replication
Recent studies in yeast have suggested that ATR may
play a role in stabilizing stalled DNA replication forks.
For example, stalled replication in Rad53mutants, a con-
ventional protein kinase that lies downstream of the
ATR ortholog in S. cerevisiae Mec1, results in replica-
tion fork collapse and DSB formation (Lopes et al. 2001).
More recently, Mec1 has been shown to prevent genera-
tion of DSBs at slowly replicating regions of the genome
(Cha and Kleckner 2002). These results have suggested a
role for Mec1-dependent checkpoint signaling to stabi-
lize stalled replication forks and prevent the generation
of DSBs (Carr 2002). We therefore reasoned that genera-
tion of such breaks in aphidicolin-treated ATR knockout
cells may play a role in preventing cell cycle progression
in a manner that is independent of ATR’s cell cycle-
inhibitory functions.
To test if ATR is required to prevent generation of
DSBs in the event of stalled DNA replication, we first
used H2AX phosphorylation as a marker of DSB forma-
tion in wild-type and ATR/− MEFs. H2AX is phosphory-
lated on serine 139 in response to IR-induced DSBs and
in the course of VDJ recombination (Rogakou et al. 1998;
Chen et al. 2000). Other forms of DNA damage cause
only mild phosphorylation of H2AX (Burma et al. 2001),
indicating that phosphorylation may be DSB-specific. Fi-
nally, recent studies indicate that phosphorylation of
H2AX is predominantly regulated by DNA-PK and ATM
Figure 5. Regulation of Chk1 and Chk2
by ATR and ATM, respectively. (A) Chk1
phosphorylation in response to either
aphidicolin or IR requires ATR. After 15 h
of FBS stimulation, Cre-expressing wild-
type and ATRflox/− MEFs were treated with
aphidicolin or IR. Lysates were prepared at
various times posttreatment, and Western
blots were detected for phospho-S345
Chk1 (upper panel) or total Chk1 (lower
panel). (B) Chk2 phosphorylation in re-
sponse to aphidicolin and IR is not depen-
dent on ATR. Samples generated as in A
were Western-blotted and detected for
Chk2. The slower-migrating phosphory-
lated and faster-migrating unphosphory-
lated forms are indicated.
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(Paull et al. 2000; Burma et al. 2001), and consistent with
this analysis we have seen no effect of ATR loss on
H2AX phosphorylation in response to IR (data not
shown). Therefore, if DSBs are generated in ATR/− upon
stalled DNA replication, then aphidicolin treatment
should cause a strong increase in H2AX phosphorylation
specifically in ATR knockout cells and little increase in
wild-type cells. To assay for increased H2AX phosphory-
lation, lysates were prepared from wild-type and ATR/−
cells that were treated or left untreated with aphidicolin
for various times. Western blots of these lysates were
then incubated with phospho-specific H2AX antibodies.
As shown in Figure 7A, little increase in H2AX phos-
phorylation occurred in wild-type cells upon aphidicolin
treatment, consistent with previous studies (Burma et al.
2001). In contrast, a robust increase in H2AX phosphory-
lation was observed in ATR/− cells after 1 h of aphidi-
colin treatment and beyond (Fig. 7A). These experiments
support a model in which ATR is required to prevent the
formation of DSBs upon stalled DNA replication.
If breaks were induced by stalled DNA replication spe-
cifically in ATR-depleted cells, then it was conceivable
that these breaks might somehow prevent mitotic entry
in an ATR/ATM-independent manner. To test this pos-
sibility and to further analyze ATR’s involvement in pre-
venting the appearance of DSBs, a chromosome spread-
based assay was developed. In this assay (Fig. 7B), short-
term treatment with aphidicolin was used to cause
replication fork stalling, but this treatment was followed
by removal of aphidicolin to allow cells to proceed into
mitosis. Then, 2.5 h after removal of aphidicolin,ATR/−
and control cells began to enter and accumulate in mi-
tosis over the course of a 1.5-h nocodazole pile-up assay.
Both mitotic spread quantitation (Fig. 7C) and phospho-
histone H3 assays (data not shown) indicated that upon
aphidicolin release, ATR/− cells were only slightly in-
hibited from entering mitosis in comparison with con-
trol cells. Importantly, these results indicate that aphidi-
colin-treated ATR/− cells have the ability to enter mi-
tosis once inhibition of DNA replication is alleviated.
Mitotic spreads prepared from cells treated as above
(Fig. 7C) were then analyzed for the percentage of mitotic
cells exhibiting DSBs. The degree of chromosome break-
age was categorized into three groups: normal (N), 1–10
breaks, and >10 breaks per mitotic spread (Fig. 7D). Few
wild-type mitotic spreads had chromosome breaks either
with or without aphidicolin treatment (Fig. 7E). A simi-
lar lack of aphidicolin-induced chromosome breaks was
observed in ATM−/− cells (data not shown). In contrast,
∼40% of ATR/− mitotic cells exhibited some form of
chromosome breakage even in the absence of aphidicolin
treatment, most with <10 chromatid breaks per cell.
These results are consistent with the chromosome
breakage observed in previous ATR knockout studies
(Brown and Baltimore 2000). However, when ATR-de-
pleted cells were treated with aphidicolin for 2 h and
then released into mitosis, an increase both in the degree
of breakage per cell and in the percentage of cells exhib-
iting breaks was observed (Fig. 7E). The most dramatic
difference was an increase in spreads exhibiting an ex-
treme form of breakage, such as that shown in Figure 7D
(>10 breaks). Because no differences in Annexin V stain-
ing were observed between wild-type and ATR knockout
cells, either treated or left untreated with aphidicolin
(Fig. 7F), the chromosome breakage apparent in aphidi-
colin-treated ATR/− cells is unlikely to be the result of
an apoptotic program. Thus, ATR/− cells can enter mi-
tosis after aphidicolin release (Fig. 7C) and do so despite
the presence of extensive chromosome breakage (Fig. 7E).
These experiments demonstrate that although ATR is
required for genome stability in the absence of exog-
enous treatment, it is particularly required in the event
of stalled DNA replication. Moreover, the DSBs gener-
ated in aphidicolin-treated ATR/− cells themselves do
not prevent mitotic entry because entry with breaks is
observed once DNA replication is allowed to proceed
(Fig. 7C). The ability of aphidicolin-released ATR/− cells
to proceed into mitosis with breaks is consistent with
the IR checkpoint studies described here, because IR also
generates DSBs and ATR/− cells continue to enter mi-
tosis despite IR treatment. The implications of these re-
sults for our understanding of checkpoint control and for
ATR’s cell cycle regulatory and genome maintenance
functions are discussed below.
Figure 6. Cdc2 phosphorylation on T14 and Y15. (A) Cdc2 is
phosphorylated normally as cells enter S phase. After 18 h of
FBS stimulation, lysates from lenti-Cre-infected ATRflox/− cells
were generated and subjected to SDS-PAGE and Western blot
detection of Cdc2. The unphosphorylated (fastest-migrating),
singly phosphorylated (phospho-T14 or phospho-Y15), and dou-
bly phosphorylated (slowest-migrating, phospho-T14 and phos-
pho-Y15) forms of Cdc2 are indicated. (B) Accumulation of
phospho-T14/Y15 Cdc2 following aphidicolin or IR does not
occur in ATR/− cells. After 15 h of FBS stimulation, Cre-ex-
pressing wild-type and ATRflox/− cells were either left untreated
(nt) or treated with either aphidicolin (Aph) or 20 Gy of -radia-
tion (IR). Cells were then harvested 9 and 12 h after treatment,
and lysates were Western-blotted and detected for Cdc2 as in A.
ATR’s role in checkpoints and genome maintenance
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Discussion
Using a Cre/lox-conditional system to study the effect of
ATR loss, we have shown that ATR is an important
regulator of checkpoint signaling pathways that are in-
duced by IR and stalled DNA replication and lead to
inhibitory phosphorylation of Cdc2. Despite this simi-
larity, IR and stalled replication cause cell cycle delay in
ways that differ in their requirements for this ATR-de-
pendent pathway. Whereas loss of ATR eliminates IR-
induced cell cycle delay, it has little effect on the delay
induced by stalled DNA replication. It is clear that ATR
regulates important arms of both the IR and DNA repli-
cation checkpoints through Cdc2 phosphorylation; how-
ever, these data also indicate that stalled DNA replica-
tion can prevent mitotic entry in an ATR-independent
manner as well. These data are consistent with the ex-
istence of multiple independent mechanisms to prevent
premature mitotic entry when DNA replication remains
incomplete.
Figure 7. Aphidicolin causes DSBs in ATR-depleted cells, but DSBs do not prevent mitotic entry upon aphidicolin release. (A)
Aphidicolin causes phosphorylation of H2AX in ATR/− cells. At 15 h of FBS stimulation, lenti-Cre-infected wild-type and ATRflox/−
cells were left untreated or treated with aphidicolin. Cells were harvested 1, 2, and 4 h later. Lysates were Western-blotted and detected
for phosphohistone H2AX. (B) Schematic representation of an assay to quantitate the effect of DSBs on preventing mitotic entry and
detect increased chromosome breakage upon aphidicolin treatment. (C) Mitotic entry of aphidicolin-treated wild-type andATR/− cells
after aphidicolin release. After a 2-h aphidicolin treatment, Cre-expressing wild-type and ATRflox/− MEFs were washed four times with
10% FBS DMEM to remove aphidicolin. Two and a half hours later, cells were collected in mitosis by nocodazole treatment (0.5 µM)
for 1.5 h. Chromosome spreads were prepared to quantitate the percentage of cells entering mitosis and to assess chromosome breakage
as described in D and E below. Cells were released from or maintained in aphidicolin as indicated. (D) Mitotic spreads with differing
degrees of chromosome breakage were observed and quantitated using the assay described in B and C. Examples of spreads with 1–10
breaks and >10 breaks are shown. (E) Aphidicolin induces breaks specifically in ATR/− cells. Cre-expressing wild-type and ATRflox/−
MEFs released from aphidicolin treatment as described in B and C (+Aph & Release) were analyzed for the frequency of each category
of mitotic chromosome spread shown in D. The chromosome breakage observed in cells left untreated with aphidicolin is also shown
(−Aph). N, normal chromosome spread. (F) Aphidicolin treatment does not cause apoptosis in ATR/− cells. Cre-expressing wild-type
and ATRflox/− MEFs left untreated, treated with aphidicolin, or treated with and released from aphidicolin were stained for Annexin
V and quantitated by flow cytometry.
Brown and Baltimore
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ATR and ATM involvement
in IR-induced cell cycle delay
Our studies demonstrate that ATR and ATM cooperate
in preventing mitotic entry in response to IR. This re-
sponse involves a complex network of checkpoint sig-
naling molecules with differing requirements for ATR
and ATM. For example, our results indicate that ATR is
the chief regulator of Chk1 phosphorylation but has no
involvement in Chk2 phosphorylation in response to ei-
ther IR or stalled replication. Because Chk2 phosphory-
lation has been previously shown to mostly require
ATM (Matsuoka et al. 1998), these results imply that
there is little if any overlap in Chk1 and Chk2 regulation
by ATR and ATM, respectively. In contrast, direct phos-
phorylation of p53 on serine 18 is codependent on ATR
and ATM in a time-dependent manner (ATM involved in
the early phase, ATR in the late). The importance of
these differences in signaling partnerships and kinetic
dependence remains unclear, but it may be related to the
manner in which DSBs are initially sensed and later pro-
cessed for repair as discussed below.
We have shown that ATR assists in the early phase of
mitotic delay in response to IR and is particularly re-
quired for the late phase. In contrast, ATM appears to be
more noticeably important for the early phase, as shown
in previous studies (Xu et al. 2002). There are at least two
conceivable models to explain the time-dependent re-
quirements for ATR and ATM. One explanation is that
the initial form of DNA breakage caused by IR is best
recognized by ATM, whereas the repair intermediates
that result from later processing of these initial breaks
are better recognized by ATR. Thus, in this model ATR
and ATM are specialized to elicit checkpoint responses
to DSBs that are in various stages of processing, and until
repair is complete these checkpoint responses remain
active. Another model involves the cell cycle phase in
which damage is sensed; for example, ATR may be par-
ticularly apt at sensing damage during DNA synthesis,
but not afterwards in the G2 phase. Nevertheless, ac-
cording to either model the differing activation of signal-
ing pathways, such as Chk1 and Chk2, by ATR and ATM
may reflect specific downstream cellular responses to
distinct stages of DNAmetabolism. Because ATR, ATM,
Chk1, and Chk2 have been shown to differentially phos-
phorylate various genes involved in DNA repair, such as
BRCA1, NBS1, Blm1, and others (Kastan and Lim 2000;
Tibbetts et al. 2000; Zhou and Elledge 2000), it is tempt-
ing to speculate that downstream processes may include
influencing the appropriate type of repair. The differing
roles of ATR–Chk1 and ATM–Chk2 pathways in such a
repair capacity, however, have not been formally tested.
The DNA replication checkpoint
We show that ATR regulates an important arm of the
DNA replication checkpoint as indicated by ATR’s re-
quirement for activating phosphorylation of Chk1 and
inhibitory phosphorylation of Cdc2 on T14/Y15. Based
on decades of research on Cdc2 regulation, there is little
doubt that phosphorylation of Cdc2 on T14/Y15 can be
an important part of cell cycle checkpoint regulation
(Norbury and Nurse 1992; Weinert 1997; Nyberg et al.
2002). However, given that cell cycle delay still occurs
even in the absence of ATR, at least one additional
mechanism to prevent premature mitotic entry must be
at work in MEFs. It is formally possible that this addi-
tional mechanismmay function using levels of ATR pro-
tein that are far below those required for regulation of
Cdc2 T14/Y15 phosphorylation; however, there is no
evidence at the present time to assume this is the case.
The simplest explanation of our data is that the Cdc2
T14/15-independent mechanism is also independent of
ATR. The ATR-independent mechanism of inhibition is
not the result of a general loss of cellular function be-
cause ATR/− cells remain capable of entering mitosis
once DNA replication inhibitors have been removed.
Therefore, some aspect of inhibited DNA replication it-
self must be responsible for the ATR-independent mi-
totic delay. It is important to point out that deletion of
the ATR orthologs MEC1 and RAD3 in budding and fis-
sion yeast, respectively, eliminate the DNA replication
checkpoint (Al-Khodairy and Carr 1992; Enoch et al.
1992; Weinert et al. 1994; Boddy et al. 1998; Nyberg et al.
2002). Thus, our results indicate that incompletely rep-
licated DNA in mammalian cells prevents mitotic entry
differently than in yeast.
Our studies indicate that Cdc2/cyclin B itself may be
the target of the ATR-independent mechanism of inhi-
bition. This interpretation is based on previous studies
implying that histone H3 phosphorylation is down-
stream of Cdc2/cyclin B activation (De Souza et al. 2000)
and on our studies showing that aphidicolin-treatment
of ATR/− cells prevents activation of cyclin B1-associ-
ated kinase activity (Fig. 4B). There are many possible
mechanisms by which Cdc2/cyclin B1 can be inhibited
other than Cdc2 T14/Y15 phosphorylation (Weinert
1997). Along these lines, it is important to point out that
a titratable inhibitor of Cdc2/cyclin B kinase activity
that acts independently of Cdc2 T14/Y15 phosphoryla-
tion has been previously observed in aphidicolin-treated
Xenopus extracts (Kumagai and Dunphy 1995). It is pos-
sible that an equivalent inhibitor is at work in mamma-
lian cells, one that acts independently of ATR and pre-
vents Cdc2/cyclin B activation when DNA replication is
left incomplete.
ATR prevents the appearance
of DSBs upon stalled DNA replication
Previous work in yeast has indicated important roles for
the ATR ortholog Mec1 and Mec1-dependent signaling
pathways (Rad53) in preventing DSB upon slowing or
stalled DNA replication (Lopes et al. 2001; Cha and
Kleckner 2002). The studies described herein confirm an
important role for ATR in preventing DSBs during
stalled DNA replication in mammalian cells. Because
ATR also regulates cell cycle checkpoint signaling path-
ways, such as Chk1 phosphorylation and Cdc2 inhibi-
tion, our studies indicate that ATR affects both cell cycle
ATR’s role in checkpoints and genome maintenance
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regulation and genome maintenance in the event of
stalled replication. It is interesting to note that, as a
mammalian ortholog of Rad53, Chk1 may be the com-
mon regulator of both the checkpoint and genome main-
tenance functions downstream of ATR. Chk1 knockout
mice die early in development, similar to ATR knockout
mice (Liu et al. 2000). Although it is not known whether
Chk1 knockout cells exhibit a form of genomic instabil-
ity similar to that observed in ATR knockouts (Brown
and Baltimore 2000), dominant-negative Chk1 overex-
pression has been reported to affect genome stability
(Nghiem et al. 2001). The mechanism by which ATR,
and possibly Chk1, maintains stability upon stalled rep-
lication is unknown but might involve the correct pro-
cessing of regressed replication forks (Carr 2002) or sta-
bilization of stalled forks by translesion bypass (Kai and
Wang 2003), a process that is not inhibited by aphidico-
lin.
Processive PIK-related kinase activation?
Our data suggest a model in which ATR, ATM, and
DNA-PK act in multiple layers to preserve genomic in-
tegrity. For example, we show that ATR is important to
prevent DSB formation in the event of stalled DNA rep-
lication and that H2AX is phosphorylated when these
breaks form in ATR’s absence (Fig. 7A). H2AX has pre-
viously been shown to be phosphorylated by ATM and
DNA-PK at the sites of DSB formation (Rogakou et al.
1999; Burma et al. 2001). Thus, if ATR is unavailable to
prevent DSB formation in the event of stalled replica-
tion, then these breaks are likely sensed by DNA-PK
and/or ATM, which then go on to phosphorylate H2AX.
It is interesting to point out that H2AX has recently been
shown to be required for efficient homologous recombi-
nation (Celeste et al. 2002); therefore, it is possible that
phosphorylation of H2AX may be part of a process to
repair these breaks or reinitiate replication fork progres-
sion (Cox et al. 2000). Although purely speculative at
this time, our studies are consistent with the possibility
that the multiple pathways in checkpoint regulation not
only respond differently to the initial forms of DNA
damage, but may also act in layers of activation that
processively safeguard genomic integrity should an up-
stream system fail.
Materials and methods
Generation of mice with a lox-conditional allele of ATR
and MEFs preparation
D3 ES cells were transfected with the targeting vector shown
(Fig. 1A), selected in neomycin, and cloned as described (Brown
and Baltimore 2000). To remove the neomycin cassette,
pCAGGS-FLPe (Buchholz et al. 1998) was transfected into re-
combined ES cells, and these cells were transiently selected in
puromycin (2 µg/mL) for 2 d, expanded for 5 d, and then selected
in gancylovir (1.5 µM) for 4 d. ES cell clone DNA was analyzed
by Southern blot as described (Brown and Baltimore 2000). To
produce ATRflox/− and control MEFs, ATR+/− (Brown and Balti-
more 2000) and ATRflox/+ mice were mated and E14.5 embryos
were isolated. MEFs prepared from these embryos were grown
in 10% FBS DMEM, genotyped, and infected with lenti-Cre vi-
rus within 2 or 3 doublings after isolation, as described below.
ATRflox/− ATM−/− and ATRflox/− p53−/− MEFs were isolated
similarly using the following parental crosses: ATRflox/flox
ATM+/− × ATR+/− ATM+/− mice and ATRflox/flox p53+/− × ATR+/−
p53+/− mice. These parental genotypes were produced by breed-
ing ATRflox/+ and ATR+/− (Brown and Baltimore 2000) mice with
ATM+/− (Xu and Baltimore 1996) and p53+/− (Jacks et al. 1994)
mice; progeny were subsequently intercrossed.
Lenti-Cre constructs and infection of MEFs
Cre-expressing lentiviruses were produced using retroviral ex-
pression vectors (Lois et al. 2002) and a packaging system pre-
viously described (Dull et al. 1998). Concentrated lenti-Cre
preparations were titered using a lox-recombination reporter
cell line [NIH3T3-lox-Lac Z, provided by Carlos Lois (Massa-
chusetts Institute of Techology, Cambridge, MA) and Dan Van
Antwerp (California Institute of Technology, Pasadena, CA)].
To recombine the ATRflox allele, MEFs were trypsinized and
resuspended at 1 × 106 cells/mL in 0.5% FBS DMEM and re-
plated in the same media containing concentrated lenti-Cre vi-
rus (1–3 × 108 TU/mL) at a multiplicity of infection (m.o.i.) of
5–10. This m.o.i. consistently resulted in expression of Cre in
>90% of the cells, as expected by Poisson distribution. At 18–24
h after the start of infection, virus-containing media was re-
moved and fresh 0.5% FBS DMEM was applied. The studies
described herein were replicated using two forms of Cre recom-
binase, NLS-Cre (provided by J. Jacob, Emery University) and
Cre-ERT2 (Feil et al. 1997), both of which recombined the
ATRflox allele with similar efficiency and produced similar
results.
Propidium iodide, phosphohistone H3,
and Annexin V staining
MEFs were tyrpsinized, washed in PBS, stained as described
below, and analyzed using a Becton Dickinson FACScan flow
cytometer (488 nm excitation laser). For propidium iodide stain-
ing, cells were resuspended in a solution containing 50 µg/mL
propidium iodide, 0.1% Triton X-100, 50 µg/mL RNAse A, and
5 mM EDTA at room temperature for 1 h. This solution was
then diluted 1:1 in 2% FBS PBS for cytometric analysis. For
Annexin V staining, PBS-washed cells were resuspended in 2%
FBS PBS containing 1 mM CaCl2 and a 1:100 dilution of An-
nexin V-PE (BD Pharmingen), incubated on ice for 15–30 min,
and analyzed for PE emission by flow cytometry. Phosphohis-
tone H3 staining was performed by a procedure similar to that
previously described (Xu et al. 2002). Briefly, cells were fixed in
ice cold 70% ethanol for 1 h, followed by fixation in ice cold
95% ethanol/5% acetic acid for 5 min. Cells were washed twice
with PBS and then permeabilized in 1% FBS/0.1% Triton X-100
PBS (FTP) for 30 min, followed by staining in 2 µg/mL anti-
phosphohistone H3 antibody (Upstate Biotechnology) in FTP at
room temperature (RT) for 1.5 h. Cells were then washed twice
in FTP and incubated with FITC-conjugated anti-rabbit F(ab)2
antibody (Jackson ImmunoResearch) in FTP at RT for 1.5 h.
After two additional washes in FTP, phosphohistone H3-posi-
tive cells were quantitated by flow cytometric detection of FITC
emission.
Mitotic spread preparation and quantitation
Mitotic spreads were prepared fromMEFs by methods described
previously (Brown and Baltimore 2000). Slides of chromosome
Brown and Baltimore
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spreads were stained and mounted in SYBR green (Molecular
Probes) diluted 1:10,000 in 85% glycerol/15% PBS at pH 7.9. To
determine the percentage of cells in mitosis, the total number of
mitotic spreads (normal + fragmented) were counted and di-
vided by the total number of cells (interphase + mitotic). For
measuring mitotic entry, >500 cells were counted for each rep-
licate. Classification of chromosome fragmentation state (Fig.
7E) was performed by analyzing >50 mitotic spreads for each of
four experiments per condition.
Cyclin B1-associated H1 kinase assays
Cells were washed with 4°C PBS and then lysed at 4°C in 1 mL
of PIP buffer (Brown et al. 1994) containing 150 mM NaCl and
no DTT for 30 min. Lysates were then clarified by centrifuga-
tion, and 1 µg of anti-Cyclin B1 monoclonal antibody (CB-169,
Upstate Biotechnology) was added to supernatants. After 2 h of
gentle agitation, 5 µL of (packed) protein A/G beads (Oncogene
Sciences) was added and incubated with extract for an addi-
tional 45 min. Beads were then washed four times with lysis
buffer and once with kinase reaction buffer (50 mM HEPES at
pH 7.5, 10 mMMgCl2, 50 mM 2-glycerophosphate, 0.1% Triton
X-100, and 1 mM DTT). Kinase reactions were initiated by the
addition of 30 µL of kinase reaction buffer containing 5 µg of
histone H1 (Roche) and 50 µM 32P--ATP (1.67 Ci/mmole) and
incubated at 37°C for 10 min. Reactions were stopped by addi-
tion of 40 µL of 2× Laemmli sample buffer and boiling for 5 min.
Phosphorylation of H1 was quantitated following SDS-PAGE by
autoradiography (Fig. 4B) and by a Molecular Dynamics Storm
860 PhosphorImager (Fig. 4B, graph).
Antibodies and Western blot detection
Whole-cell extracts were prepared by lysing cells in Laemmli
sample buffer, separating proteins by SDS-PAGE, and blotting
to either nitrocellulose or PVDFmembranes (Immobilon P, Mil-
lipore). Blots were blocked in TBST containing 5% nonfat dried
milk (NFDM) and incubated at RT for 1–2 h with primary an-
tibodies as follows: ATR was detected with anti-human ATR
(2381–2644) antibodies (Serotec) diluted in 1:5000 dilution in
5% NFDM TBST. Chk1 was detected with monoclonal anti-
bodies to full-length Chk1 (sc-8408, Santa Cruz Biotechnology)
diluted in 5% NFDM TBST and incubated with blots at RT for
1 h. Phosphoserine 18 of mouse p53 and phosphoserine 345
Chk1 were detected by incubation with commercially available
antibodies (#9284 and #2341, Cell Signaling Technology) at RT
for 1 h (P-S18 p53) or at 4°C for >16 h (P-S345 Chk1), diluted
1:1000 in 5% BSA TBST. Anti-Chk2 polyclonal antibodies [gift
of Steve Elledge (Baylor College, Houston, TX); Matsuoka et al.
1998] were used at a 1:500 dilution in 5% BSA at RT for 2 h.
Cdc2 and cyclin B1 were detected with 1 µg/mL dilutions of
anti-Cdc2 (Ab-3, Calbiochem) and anti-cyclin B1 (GNS-1, BD
Pharmingen) monoclonal antibodies in TBST. Finally, anti-
phosphoserine 139 H2AX antibodies (Upstate Biotechnology)
were used at a 1:1000 dilution in 3% NFDM TBST incubated
with blots at 4°C for 6 h.
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